Catalyst Wire Dossier Catalyst Wire Dossier

Belapectin

belapectin · Galectin Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Belapectin, covering 2026-02-20 to 2026-06-30. Get the full timeline:

Most recent: Clinical Trial Results: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis [Phase 2, Phase 3]

See pricing